Leading With Excellence
IntegriChain has the deepest set of drug commercialization experts in the industry. No other commercialization partner provides the depth of policy, pricing, and reimbursement insights, pulse on regulatory changes and reforms, as well as best-in-class strategy development across all aspects of drug commercialization.
Whether you’re launching your first drug or managing a portfolio of hundreds, IntegriChain’s pharma consulting services helps you build net revenue-efficient and connected strategies for access, affordability and distribution.
Why IntegriChain is a trusted advisor on healthcare strategy, process and technology
Data & Technology
Successful commercialization depends on accurate, timely insights around patient, provider, payer, distribution, pharmacy, and financial performance. IntegriChain is powered by the data and technology of the ICyte Platform, delivering tailored data strategies, technology assessments, vendor selection and implementation support, actionable analytics, and end-to-end operational support.
Distribution & Supply Chain
Selecting and structuring the right distribution model is one of the most consequential decisions in drug commercialization, with direct implications for patient access, channel costs, and GTN performance. IntegriChain consultants bring a proven track record across all distribution models and therapeutic categories, working alongside manufacturers to design optimal channel strategies and negotiate favorable agreements with third party logistics providers and distribution partners. Our services span distribution strategy, direct distribution, 3PL strategy and implementation, and network design and selection.